Trials / Completed
CompletedNCT01375998
YAZ Post-marketing Surveillance in Japan
Drug Use Investigation of YAZ
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,273 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is a regulatory post marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received YAZ for dysmenorrhea. The objective of this study is to assess safety and efficacy of using YAZ in clinical practice. A total 3,000 patients will be recruited and followed 3 years since starting YAZ administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EE20/DRSP(YAZ, BAY86-5300) | Patients in daily life treatment receiving YAZ for dysmenorrhea. |
Timeline
- Start date
- 2011-06-09
- Primary completion
- 2017-12-05
- Completion
- 2018-03-08
- First posted
- 2011-06-20
- Last updated
- 2019-03-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01375998. Inclusion in this directory is not an endorsement.